Delivery Order SPE2DB24D1107-SPE2DB25FZGD9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 13, 2025, valued at $1,201.20 for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used to...
- The Defense Logistics Agency awarded a $25,073.25 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of May 21, 2025. Trulicity is a brand-name diabetes medication widely used across military and federal healthcare systems. This is a non-set-aside competitive award with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,667.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on April 28, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by April 29, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used to improve blood sugar control in patients with type 2 diabetes,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,628.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 4, 2025. This non-set-aside, firm fixed-price delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. Trulicity is a brand-name diabetes medication commonly used within federal healthcare systems, including military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens valued at $10,644.05 on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within military and veteran...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded a $6,044.85 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $1,870.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly utilized within military and federal healthcare systems to...
- The Defense Logistics Agency awarded a $3,303.30 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a completion date of September 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used by military and veteran healthcare systems supported...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZGD9Delivery Order
The Defense Logistics Agency awarded a $13,827.64 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 3 mg/0.5 ml pens with a completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized across military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to supply an extensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical relationship reflects AmerisourceBergen's established capability as a major pharmaceutical distributor serving critical federal medical procurement needs for the Department of Defense and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 8/4/25 |